Social Support Intervention Targeting Patients Treated for Cardiac Disease Who Experience Loneliness

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05503810
Collaborator
(none)
40
1
2
27.9
1.4

Study Details

Study Description

Brief Summary

Introduction: In patients treated for cardiac disease, loneliness is known to contribute negatively to health behavior, health outcome and increase risk of cardiac and all-cause mortality. Even so, in health care research, social support interventional studies targeting patients who experience loneliness is lacking.

Aim: To determine the feasibility of an individually structured social support intervention targeting patients treated for cardiac disease who experience loneliness.

Design: A feasibility study based on randomized clinical trial design with 1:1 randomization to a 6-month social support program, plus usual care (intervention) versus usual care, (i.e., regular guidelines-based follow-up). Intervention: Patients classified as high risk lonely according to the High Risk Loneliness tool will be provided with an informal caregiver in the six months rehabilitation phase following cardiac disease treatment. The informal caregiver will be designated by the patient from the existing social network or a peer, depending on patients' preferences. The core content of the intervention is through nurse consultations at baseline, one, three and six months, to enhance and reinforce the informal caregiver's competences to be a social support resource. The theoretical framework of the nurse consolations will be based on Middle-range theory of self-care.

Outcome: Feasibility will be evaluated in terms of acceptability and adherence according to predefined feasibility criteria. The preliminary effect of the intervention on patient-reported outcomes, health behaviors and health outcomes will be evaluated in the intervention and the control group at baseline, one, three, six and twelve months.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Social support
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized clinical trial design with 1:1 randomizationRandomized clinical trial design with 1:1 randomization
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Feasibility Randomized Trial of a Social Support Intervention Plus Usual Care Versus Usual Care, Targeting Patients Treated for Cardiac Disease Who Experience Loneliness
Anticipated Study Start Date :
Sep 5, 2022
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Six month social support intervention following in hospital cardiac treatment

Behavioral: Social support
Contact ones a week with Informal caregiver or peer support
Other Names:
  • Loneliness reduction
  • No Intervention: Control

    Regular follow-up

    Outcome Measures

    Primary Outcome Measures

    1. Feasibility, Acceptability [Measured at baseline]

      Percentage of eligible patients who agree to participate in the trial

    2. Feasibility, Adherence [6 months follow-up after in-hospital cardiac treatment]

      Percentage of patients in contact with the informal caregiver at least once a week face to face, by phone or virtually.

    Secondary Outcome Measures

    1. Measure of social network members as informal caregivers [Measured at baseline]

      Percentage of potential caregivers who accepts to be an informal caregiver

    2. Measure of informal caregivers [3 months follow-up after in-hospital cardiac treatment]

      Percentage of informal caregivers participating in all three intervention consultations with the trial staff

    3. Resource consumption [6 months follow-up after in-hospital cardiac treatment]

      Time resources used to complete the three nurse consultations

    Other Outcome Measures

    1. Loneliness [Baseline, one, three, six and twelve months]

      High Risk Loneliness tool. 2 item. Screeningscore 0 to 2, with a higher score indicating worse outcome

    2. Self-care [Baseline, one, three, six and twelve months]

      Self Care Self-Efficacy scale. 10 item scale answered on a Likert scale 1 to 5 with a lower score indicating worse outcome

    3. Health-related quality of life [Baseline, one, three, six and twelve months]

      HeartQoL. 10 item scale answered on a Likert scale 0-5, with a higher score indicating worse outcome

    4. Anxiety and Depression [Baseline, one, three, six and twelve months]

      Hospital Anxiety and Depression scale (HADS). 14 item scale. The scale offers two scores, HADS-A (anxiety) and HADS-D (depression). Answered in a Likert scale with a higher score indicating worse outcome

    5. Health behaviors [Baseline, one, three, six and twelve months]

      Smoking, alcohol consumption, weight, physical activity, participation in cardiac rehabilitation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients treated for Ischemic heart disease (CABG or PCI), valve disease (TAVR, SAVR), and arrhythmia (ICD, pacemaker implantation or ablation) treated at Rigshospitalet and classified as high risk lonely according to the High Risk Loneliness (HiRL) tool
    Exclusion Criteria:
    • Patients who are unable to provide written consent, therefore, patients with severe cognitive or physical dysfunction will not be approached

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Rigshospitalet, Copenhagen University Hospital Copenhagen Denmark

    Sponsors and Collaborators

    • Rigshospitalet, Denmark

    Investigators

    • Principal Investigator: Selina K Berg, Professor, Rigshospitalet, Denmark
    • Study Director: Mitti Blakø, PhD, Rigshospitalet, Denmark
    • Study Chair: Anne V Christensen, PhD, Rigshospitalet, Denmark
    • Study Chair: Pernille Palm, PhD, Rigshospitalet, Denmark
    • Study Chair: Ida E Hojskov, PhD, Rigshospitalet, Denmark
    • Study Chair: Camilla Bernild, PhD, Rigshospitalet, Denmark

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Selina Kikkenborg Berg, Professor, Rigshospitalet, Denmark
    ClinicalTrials.gov Identifier:
    NCT05503810
    Other Study ID Numbers:
    • HeartBuddyPilot
    First Posted:
    Aug 17, 2022
    Last Update Posted:
    Aug 17, 2022
    Last Verified:
    Aug 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Selina Kikkenborg Berg, Professor, Rigshospitalet, Denmark
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 17, 2022